Savolitinib is an oral, potent and highly selective MET tyrosine kinase inhibitor ("TKI”) being jointly developed and commercialized by AstraZeneca and HUTCHMED. In 2023, savolitinib and TAGRISSO ® ...

Tobacco use, including smokeless products like betel quid, Ghutka, Khaini, Paan Masala etc remains the main factors in which ...

That fishy smell? It’s bacterial vaginosis. A new study shows it’s an STI, and male partners should be treated to stop the ...

Union Health Minister JP Nadda on Wednesday said the government's expenditure on healthcare has reached 1.84 per cent of GDP ...

On the occasion of World Oral Health Day, Regional Director for WHO South-East Asia, Saima Wazed brought attention towards ...

Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says. The antibiotic ...

A meta-analysis of previous studies indicates a positive effect, showing a reduced risk of certain cancers among coffee and ...

March is Blood Clot Awareness Month, and health officials are raising concerns about the risks associated with venous thrombosis, which is a blood clot in a vein.

Babies with heart birth defects appear to have a higher risk of developing childhood cancer, compared to those without a ...

A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a ...

Parmar and her student research assistants will be responsible for conducting the experiments and Cottage Health Research ...

Dogs that have oral squamous cell carcinomas often need surgery that disfigures their jaws and lower their quality of ...